1. Home
  2. PAHC vs KRP Comparison

PAHC vs KRP Comparison

Compare PAHC & KRP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PAHC
  • KRP
  • Stock Information
  • Founded
  • PAHC 1946
  • KRP 2013
  • Country
  • PAHC United States
  • KRP United States
  • Employees
  • PAHC N/A
  • KRP N/A
  • Industry
  • PAHC Biotechnology: Pharmaceutical Preparations
  • KRP Oil & Gas Production
  • Sector
  • PAHC Health Care
  • KRP Energy
  • Exchange
  • PAHC Nasdaq
  • KRP Nasdaq
  • Market Cap
  • PAHC 968.3M
  • KRP 1.1B
  • IPO Year
  • PAHC 2014
  • KRP 2017
  • Fundamental
  • Price
  • PAHC $31.10
  • KRP $14.11
  • Analyst Decision
  • PAHC Hold
  • KRP Hold
  • Analyst Count
  • PAHC 4
  • KRP 5
  • Target Price
  • PAHC $24.50
  • KRP $17.40
  • AVG Volume (30 Days)
  • PAHC 298.9K
  • KRP 562.9K
  • Earning Date
  • PAHC 08-27-2025
  • KRP 08-07-2025
  • Dividend Yield
  • PAHC 1.54%
  • KRP 12.20%
  • EPS Growth
  • PAHC 140.17
  • KRP N/A
  • EPS
  • PAHC 0.78
  • KRP 0.07
  • Revenue
  • PAHC $1,190,682,000.00
  • KRP $312,876,555.00
  • Revenue This Year
  • PAHC $28.33
  • KRP $10.45
  • Revenue Next Year
  • PAHC $13.78
  • KRP $3.27
  • P/E Ratio
  • PAHC $39.84
  • KRP $194.20
  • Revenue Growth
  • PAHC 19.12
  • KRP 3.03
  • 52 Week Low
  • PAHC $16.16
  • KRP $10.98
  • 52 Week High
  • PAHC $31.48
  • KRP $17.07
  • Technical
  • Relative Strength Index (RSI)
  • PAHC 85.38
  • KRP 56.81
  • Support Level
  • PAHC $24.59
  • KRP $13.83
  • Resistance Level
  • PAHC $30.59
  • KRP $14.29
  • Average True Range (ATR)
  • PAHC 0.86
  • KRP 0.28
  • MACD
  • PAHC 0.53
  • KRP -0.03
  • Stochastic Oscillator
  • PAHC 97.92
  • KRP 36.86

About PAHC Phibro Animal Health Corporation

Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.

About KRP Kimbell Royalty Partners Common Units Representing Limited Partner Interests

Kimbell Royalty Partners LP owns and acquires mineral and royalty interests in oil and natural gas properties throughout the United States. The company's basins and producing regions include areas of interest in the Permian Basin, Mid-Continent, Terryville/Cotton Valley/Haynesville, Appalachian Basin, Eagle Ford, Bakken/Williston Basin, and DJ Basin/Rockies/Niobrara. Its revenues are derived from royalty payments received from operators based on the sale of oil, natural gas and NGL production, as well as the sale of NGLs that are extracted from natural gas during processing.

Share on Social Networks: